The SARS-Cov-2 Proliferation Blocked by a Novel and Potent Main Protease Inhibitor via Computer-aided Drug Design

In conclusion, we suggest that ZINC31157475can potentially treat COVID-19 by inhibition of the 3CLp. However, in-vitro and in-vivo study is essential for approval of this suggestion.
Source: Iranian Journal of Pharmaceutical Research - Category: Drugs & Pharmacology Source Type: research